IMDX
Insight Molecular Diagnostics
IMDX
IMDX
90 hedge funds and large institutions have $323M invested in Insight Molecular Diagnostics in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 34 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.08% more ownership
Funds ownership: 3.07% → 3.15% (+0.08%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
24% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 34
Holders
90
Holding in Top 10
2
Calls
$1.31M
Puts
$607K
Top Buyers
| 1 | +$4.26M | |
| 2 | +$2.77M | |
| 3 | +$2.01M | |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
+$1.62M |
| 5 |
Goldman Sachs
New York
|
+$1.23M |
Top Sellers
| 1 | -$1.54M | |
| 2 | -$1.37M | |
| 3 | -$1.34M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.26M |
| 5 |
Barclays
London,
United Kingdom
|
-$567K |